Tim F. Greten
Impact in
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Immunology top 0.05%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
Papers in
- Oncology 122
- Cancer Immunotherapy and Biomarkers 58
- Pancreatic and Hepatic Oncology Research 29
- Immunology 102
- Immunotherapy and Immune Responses 50
- Immune Cell Function and Interaction 36
- Immune cells in cancer 34
- Co-authors
- Firouzeh Korangy (63 shared papers)Michael P. Manns (47 shared papers)Austin G. Duffy (49 shared papers)Lars A. Ormandy (9 shared papers)Florian R. Greten (3 shared papers)Bernd Heinrich (23 shared papers)Laurence J. Egan (1 shared paper)Jin Mo Park (1 shared paper)
- Journals
- Journal of Clinical Oncology (48 papers)Journal of Hepatology (16 papers)Hepatology (13 papers)The Journal of Immunology (8 papers)Cancer Research (7 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Tim F. Greten
283 papers receiving 21.9k citations
Tim F. Greten's Hit Papers
Peers
Comparison fields: 5 of 144
- Hepatology 4.2k
- Immunology 8.8k
- Oncology 7.1k
- Cancer Research 3.0k
- Epidemiology 2.8k
Countries citing papers authored by Tim F. Greten
This map shows the geographic impact of Tim F. Greten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim F. Greten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim F. Greten more than expected).
Fields of papers citing papers by Tim F. Greten
This network shows the impact of papers produced by Tim F. Greten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim F. Greten. The network helps show where Tim F. Greten may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim F. Greten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 293 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards Hit paper breakdown → | 2016 | 2054 |
| 2 | IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer Hit paper breakdown → | 2004 | 2016 |
| 3 | EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer Hit paper breakdown → | 2012 | 1231 |
| 4 | Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma Hit paper breakdown → | 2021 | 678 |
| 5 | A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells Hit paper breakdown → | 2008 | 655 |
| 6 | NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis Hit paper breakdown → | 2016 | 582 |
| 7 | Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer Hit paper breakdown → | 2019 | 536 |
| 8 | Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor # Hit paper breakdown → | 2009 | 534 |
| 9 | Increased Populations of Regulatory T Cells in Peripheral Blood of Patients with Hepatocellular Carcinoma Hit paper breakdown → | 2005 | 526 |
| 10 | Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression Hit paper breakdown → | 2016 | 456 |
| 11 | 2011 | 331 | |
| 12 | 2014 | 321 | |
| 13 | Single‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma Hit paper breakdown → | 2018 | 270 |
| 14 | Gut microbiome in HCC – Mechanisms, diagnosis and therapy Hit paper breakdown → | 2020 | 269 |
| 15 | 2008 | 261 | |
| 16 | 2016 | 250 | |
| 17 | 2015 | 250 | |
| 18 | Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference Hit paper breakdown → | 2020 | 250 |
| 19 | 2020 | 226 | |
| 20 | Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment Hit paper breakdown → | 2023 | 223 |
About Tim F. Greten
Tim F. Greten is a scholar working on Oncology, Immunology, Hepatology, Molecular Biology and Surgery, having authored 293 papers that have together received 22.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (61 papers), Cancer Immunotherapy and Biomarkers (58 papers), Immunotherapy and Immune Responses (50 papers), Immune Cell Function and Interaction (36 papers), Immune cells in cancer (34 papers), Pancreatic and Hepatic Oncology Research (29 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (28 papers) and Cancer Genomics and Diagnostics (21 papers). The work is most often cited by research in Hepatology (4.2k citations), Immunology (8.8k citations), Oncology (7.1k citations), Cancer Research (3.0k citations) and Epidemiology (2.8k citations). Tim F. Greten has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Firouzeh Korangy, Michael P. Manns, Austin G. Duffy, Lars A. Ormandy, Florian R. Greten, Bernd Heinrich, Laurence J. Egan, Jin Mo Park, Martin F. Kagnoff and Josep M. Llovet. Their work appears in journals such as Journal of Clinical Oncology, Journal of Hepatology, Hepatology, The Journal of Immunology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.